Application | Comment | Organism |
---|---|---|
drug development | human enzyme MMP-3, i.e. stromelysin-1, is an anti-cancer drug target | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
5-methyl-5-(4-phenoxy-phenyl)-pyrimidine-2,4,6-trione | MPPT, enzyme binding structure analysis | Homo sapiens | |
curcumin | i.e. 1,7-bis (4-hydroxy-3-methoxyphenol)-1,6-heptadiene-3,5-dione, molecular docking and prediction of binding interactions of curcumin with active site residues | Homo sapiens | |
additional information | interactions of curcumin with MMP-3 are compared to those of two known inhibitors of the enzyme, PBSA and MPPT, curcumin binds with affinity comparable to or better than the two known inhibitors | Homo sapiens | |
[4-(4-phenyl-piperidin-1-yl)-benzenesulfonylamino]-acetic acid | PBSA, enzyme binding structure analysis | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
extracellular | - |
Homo sapiens | - |
- |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Ca2+ | required, the catalytic domains contain Ca2+ ions | Homo sapiens | |
Zn2+ | a zinc metalloproteinase | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P08254 | - |
- |
Synonyms | Comment | Organism |
---|---|---|
MMP-3 | - |
Homo sapiens |
stromelysin-1 | - |
Homo sapiens |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.000036 | - |
curcumin | pH and temperature not specified in the publication | Homo sapiens | |
0.00005 | - |
5-methyl-5-(4-phenoxy-phenyl)-pyrimidine-2,4,6-trione | pH and temperature not specified in the publication | Homo sapiens | |
0.000098 | - |
[4-(4-phenyl-piperidin-1-yl)-benzenesulfonylamino]-acetic acid | pH and temperature not specified in the publication | Homo sapiens |
General Information | Comment | Organism |
---|---|---|
additional information | the active site of MMPs consists of two distinct regions: a groove in the protein surface, centered on the catalytic zinc ion and an S1 specificity site that varies considerably among members of the family. Bound inhibitors adopt extended conformations within the groove, make several hydrogen bonds with the enzyme and provide the fourth ligand for the catalytic zinc ion. The S1 subsite apparently plays a significant role in determining the substrate specificity in the active enzymes | Homo sapiens |